These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 6303744)

  • 1. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Sep; 14(3):163-97. PubMed ID: 143363
    [No Abstract]   [Full Text] [Related]  

  • 4. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
    Frishman WH; Eisen G; Lapsker J
    Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of prazosin as initial antihypertensive therapy.
    Okun R
    Am J Cardiol; 1983 Feb; 51(4):644-50. PubMed ID: 6829427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1977 Apr; 4(2):141-5. PubMed ID: 577181
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute systemic and regional haemodynamic profile of prazosin in conscious hypertensive rabbits.
    Bolt GR; Saxena PR
    Eur J Pharmacol; 1984 Sep; 104(1-2):151-7. PubMed ID: 6499911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effects of prazosin and phenoxybenzamine on arterial pressure, heart rate and plasma catecolamines in essential arterial hypertension].
    Mulvihill-Wilson J; Graham RM; Pettinger WA; Muckleroy C; Anderson S; Gaffney F; Blomqvist CG
    Cardiology; 1980; 66 Suppl 2():85-93. PubMed ID: 6116543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of blood pressure response and the renin-angiotensin system to first-dose prazosin.
    Nicholson JP; Resnick LM; Pickering TG; Marion R; Sullivan P; Laragh JH
    Am J Med; 1985 Feb; 78(2):241-4. PubMed ID: 3881942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive monotherapy with prazosin].
    Liebau G; Baetzner P; Futter G; Hayduk K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():308-11. PubMed ID: 347803
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
    Taylor SH; Silke B
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):45-51. PubMed ID: 6124209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin in chronic congestive heart failure due to ischemic heart disease.
    Antani JA; Antani NJ; Nanivadekar AS
    Clin Cardiol; 1991 Jun; 14(6):495-500. PubMed ID: 1810687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin in hypertension with heart failure.
    Antani JA
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S56-62. PubMed ID: 94640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL; Vincent J
    Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic prazosin treatment on the renin-angiotensin-aldosterone system in man.
    Barbieri C; Ferrari C; Caldara R; Rampini P; Crossignani RM; Bergonzi M
    J Clin Pharmacol; 1981 Oct; 21(10):418-23. PubMed ID: 7309905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.